Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-positive non-small cell lung cancer

Abstract Background Mesenchymal-epithelial transition exon14 (METex14) skipping is one of the therapeutic driver oncogene mutations in non-small cell lung cancer (NSCLC), and can be treated with tepotinib and capmatinib. There is only one report on computed tomography (CT) findings of METex14 skippi...

Full description

Bibliographic Details
Main Authors: Naokazu Watari, Kakuhiro Yamaguchi, Hiroaki Terada, Kosuke Hamai, Ken Masuda, Yoshifumi Nishimura, Shinjiro Sakamoto, Takeshi Masuda, Yasushi Horimasu, Shintaro Miyamoto, Taku Nakashima, Hiroshi Iwamoto, Hiroyasu Shoda, Nobuhisa Ishikawa, Kazunori Fujitaka, Kozue Miyazaki, Yoshihiro Miyata, Hironobu Hamada, Kazuo Awai, Noboru Hattori
Format: Article
Language:English
Published: BMC 2022-06-01
Series:BMC Pulmonary Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12890-022-02037-4
_version_ 1811328797383852032
author Naokazu Watari
Kakuhiro Yamaguchi
Hiroaki Terada
Kosuke Hamai
Ken Masuda
Yoshifumi Nishimura
Shinjiro Sakamoto
Takeshi Masuda
Yasushi Horimasu
Shintaro Miyamoto
Taku Nakashima
Hiroshi Iwamoto
Hiroyasu Shoda
Nobuhisa Ishikawa
Kazunori Fujitaka
Kozue Miyazaki
Yoshihiro Miyata
Hironobu Hamada
Kazuo Awai
Noboru Hattori
author_facet Naokazu Watari
Kakuhiro Yamaguchi
Hiroaki Terada
Kosuke Hamai
Ken Masuda
Yoshifumi Nishimura
Shinjiro Sakamoto
Takeshi Masuda
Yasushi Horimasu
Shintaro Miyamoto
Taku Nakashima
Hiroshi Iwamoto
Hiroyasu Shoda
Nobuhisa Ishikawa
Kazunori Fujitaka
Kozue Miyazaki
Yoshihiro Miyata
Hironobu Hamada
Kazuo Awai
Noboru Hattori
author_sort Naokazu Watari
collection DOAJ
description Abstract Background Mesenchymal-epithelial transition exon14 (METex14) skipping is one of the therapeutic driver oncogene mutations in non-small cell lung cancer (NSCLC), and can be treated with tepotinib and capmatinib. There is only one report on computed tomography (CT) findings of METex14 skipping-positive NSCLC, which shows that the primary tumor tends to have a large mass in the upper lobe, and extrathoracic metastases are common. This study examined the CT findings of METex14 skipping-positive NSCLC, focusing on the features of the margins and internal structures. Methods We consecutively included patients with METex14 skipping-positive NSCLC who were diagnosed between January 2018 and December 2020 at four independent institutions. We retrospectively reviewed the patient demographics and CT findings for tumor margins (invasion into surrounding tissue, lobulation, pleural indentation, spicula, and ground-glass opacity) and internal structures (air bronchograms, cavitation and internal low-density area). Results Fifteen patients with METex14 skipping-positive NSCLC were identified. Almost half of the patients were men (7/15; 46.7%), and their median age was 75.0 years. More than half were either current or former smokers (9/15; 60.0%). A vast majority of histological subtypes were adenocarcinoma (10/15; 66.7%), followed by pleomorphic carcinoma (3/15; 20.0%) and squamous cell carcinoma (2/15; 13.3%). With regard to CT findings, most primary tumors presented as masses larger than 30 mm (12/15; 80.0%) and were located in the upper lobes (12/15; 80.0%). Invasion into surrounding tissue and presence of internal low-density areas were observed in 60.0% (9/15) and 66.7% (10/15) of the primary tumors, respectively. Additionally, their frequencies increased to 72.7% (8/11) and 90.9% (10/11) in stage III/IV cases, respectively. In lymph node metastasis, internal low-density areas were observed in 8/10 cases (80.0%). Although these two CT features were rarely observed in distant metastases at diagnosis, they became apparent with progression of the metastatic tumor size. Conclusions METex14 skipping-positive NSCLC tumors tend to invade surrounding tissue and possess internal low-density areas. These CT findings might be characteristic of METex14 skipping-positive NSCLC.
first_indexed 2024-04-13T15:31:21Z
format Article
id doaj.art-bece7498093044a7bbb19690580de0ce
institution Directory Open Access Journal
issn 1471-2466
language English
last_indexed 2024-04-13T15:31:21Z
publishDate 2022-06-01
publisher BMC
record_format Article
series BMC Pulmonary Medicine
spelling doaj.art-bece7498093044a7bbb19690580de0ce2022-12-22T02:41:22ZengBMCBMC Pulmonary Medicine1471-24662022-06-012211910.1186/s12890-022-02037-4Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-positive non-small cell lung cancerNaokazu Watari0Kakuhiro Yamaguchi1Hiroaki Terada2Kosuke Hamai3Ken Masuda4Yoshifumi Nishimura5Shinjiro Sakamoto6Takeshi Masuda7Yasushi Horimasu8Shintaro Miyamoto9Taku Nakashima10Hiroshi Iwamoto11Hiroyasu Shoda12Nobuhisa Ishikawa13Kazunori Fujitaka14Kozue Miyazaki15Yoshihiro Miyata16Hironobu Hamada17Kazuo Awai18Noboru Hattori19Department of Respiratory Medicine, Hiroshima University HospitalDepartment of Respiratory Medicine, Hiroshima University HospitalDepartment of Diagnostic Radiology, Graduate School of Biomedical and Health Sciences, Hiroshima UniversityDepartment of Respiratory Medicine, Hiroshima Prefectural HospitalDepartment of Respiratory Internal Medicine, Hiroshima City Hiroshima Citizens HospitalDepartment of Respiratory Medicine, National Hospital Organization Higashihiroshima Medical CenterDepartment of Respiratory Medicine, Hiroshima University HospitalDepartment of Respiratory Medicine, Hiroshima University HospitalDepartment of Respiratory Medicine, Hiroshima University HospitalDepartment of Respiratory Medicine, Hiroshima University HospitalDepartment of Respiratory Medicine, Hiroshima University HospitalDepartment of Respiratory Medicine, Hiroshima University HospitalDepartment of Respiratory Internal Medicine, Hiroshima City Hiroshima Citizens HospitalDepartment of Respiratory Medicine, Hiroshima Prefectural HospitalDepartment of Respiratory Medicine, Hiroshima University HospitalDepartment of Respiratory Medicine, National Hospital Organization Higashihiroshima Medical CenterDepartment of Surgical Oncology, Hiroshima UniversityDepartment of Respiratory Medicine, Hiroshima University HospitalDepartment of Diagnostic Radiology, Graduate School of Biomedical and Health Sciences, Hiroshima UniversityDepartment of Respiratory Medicine, Hiroshima University HospitalAbstract Background Mesenchymal-epithelial transition exon14 (METex14) skipping is one of the therapeutic driver oncogene mutations in non-small cell lung cancer (NSCLC), and can be treated with tepotinib and capmatinib. There is only one report on computed tomography (CT) findings of METex14 skipping-positive NSCLC, which shows that the primary tumor tends to have a large mass in the upper lobe, and extrathoracic metastases are common. This study examined the CT findings of METex14 skipping-positive NSCLC, focusing on the features of the margins and internal structures. Methods We consecutively included patients with METex14 skipping-positive NSCLC who were diagnosed between January 2018 and December 2020 at four independent institutions. We retrospectively reviewed the patient demographics and CT findings for tumor margins (invasion into surrounding tissue, lobulation, pleural indentation, spicula, and ground-glass opacity) and internal structures (air bronchograms, cavitation and internal low-density area). Results Fifteen patients with METex14 skipping-positive NSCLC were identified. Almost half of the patients were men (7/15; 46.7%), and their median age was 75.0 years. More than half were either current or former smokers (9/15; 60.0%). A vast majority of histological subtypes were adenocarcinoma (10/15; 66.7%), followed by pleomorphic carcinoma (3/15; 20.0%) and squamous cell carcinoma (2/15; 13.3%). With regard to CT findings, most primary tumors presented as masses larger than 30 mm (12/15; 80.0%) and were located in the upper lobes (12/15; 80.0%). Invasion into surrounding tissue and presence of internal low-density areas were observed in 60.0% (9/15) and 66.7% (10/15) of the primary tumors, respectively. Additionally, their frequencies increased to 72.7% (8/11) and 90.9% (10/11) in stage III/IV cases, respectively. In lymph node metastasis, internal low-density areas were observed in 8/10 cases (80.0%). Although these two CT features were rarely observed in distant metastases at diagnosis, they became apparent with progression of the metastatic tumor size. Conclusions METex14 skipping-positive NSCLC tumors tend to invade surrounding tissue and possess internal low-density areas. These CT findings might be characteristic of METex14 skipping-positive NSCLC.https://doi.org/10.1186/s12890-022-02037-4Mesenchymal-epithelial transition exon14 skippingComputed tomographyNon-small cell lung cancerDriver gene mutationImaging examination
spellingShingle Naokazu Watari
Kakuhiro Yamaguchi
Hiroaki Terada
Kosuke Hamai
Ken Masuda
Yoshifumi Nishimura
Shinjiro Sakamoto
Takeshi Masuda
Yasushi Horimasu
Shintaro Miyamoto
Taku Nakashima
Hiroshi Iwamoto
Hiroyasu Shoda
Nobuhisa Ishikawa
Kazunori Fujitaka
Kozue Miyazaki
Yoshihiro Miyata
Hironobu Hamada
Kazuo Awai
Noboru Hattori
Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-positive non-small cell lung cancer
BMC Pulmonary Medicine
Mesenchymal-epithelial transition exon14 skipping
Computed tomography
Non-small cell lung cancer
Driver gene mutation
Imaging examination
title Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-positive non-small cell lung cancer
title_full Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-positive non-small cell lung cancer
title_fullStr Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-positive non-small cell lung cancer
title_full_unstemmed Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-positive non-small cell lung cancer
title_short Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-positive non-small cell lung cancer
title_sort characteristic computed tomography features in mesenchymal epithelial transition exon14 skipping positive non small cell lung cancer
topic Mesenchymal-epithelial transition exon14 skipping
Computed tomography
Non-small cell lung cancer
Driver gene mutation
Imaging examination
url https://doi.org/10.1186/s12890-022-02037-4
work_keys_str_mv AT naokazuwatari characteristiccomputedtomographyfeaturesinmesenchymalepithelialtransitionexon14skippingpositivenonsmallcelllungcancer
AT kakuhiroyamaguchi characteristiccomputedtomographyfeaturesinmesenchymalepithelialtransitionexon14skippingpositivenonsmallcelllungcancer
AT hiroakiterada characteristiccomputedtomographyfeaturesinmesenchymalepithelialtransitionexon14skippingpositivenonsmallcelllungcancer
AT kosukehamai characteristiccomputedtomographyfeaturesinmesenchymalepithelialtransitionexon14skippingpositivenonsmallcelllungcancer
AT kenmasuda characteristiccomputedtomographyfeaturesinmesenchymalepithelialtransitionexon14skippingpositivenonsmallcelllungcancer
AT yoshifuminishimura characteristiccomputedtomographyfeaturesinmesenchymalepithelialtransitionexon14skippingpositivenonsmallcelllungcancer
AT shinjirosakamoto characteristiccomputedtomographyfeaturesinmesenchymalepithelialtransitionexon14skippingpositivenonsmallcelllungcancer
AT takeshimasuda characteristiccomputedtomographyfeaturesinmesenchymalepithelialtransitionexon14skippingpositivenonsmallcelllungcancer
AT yasushihorimasu characteristiccomputedtomographyfeaturesinmesenchymalepithelialtransitionexon14skippingpositivenonsmallcelllungcancer
AT shintaromiyamoto characteristiccomputedtomographyfeaturesinmesenchymalepithelialtransitionexon14skippingpositivenonsmallcelllungcancer
AT takunakashima characteristiccomputedtomographyfeaturesinmesenchymalepithelialtransitionexon14skippingpositivenonsmallcelllungcancer
AT hiroshiiwamoto characteristiccomputedtomographyfeaturesinmesenchymalepithelialtransitionexon14skippingpositivenonsmallcelllungcancer
AT hiroyasushoda characteristiccomputedtomographyfeaturesinmesenchymalepithelialtransitionexon14skippingpositivenonsmallcelllungcancer
AT nobuhisaishikawa characteristiccomputedtomographyfeaturesinmesenchymalepithelialtransitionexon14skippingpositivenonsmallcelllungcancer
AT kazunorifujitaka characteristiccomputedtomographyfeaturesinmesenchymalepithelialtransitionexon14skippingpositivenonsmallcelllungcancer
AT kozuemiyazaki characteristiccomputedtomographyfeaturesinmesenchymalepithelialtransitionexon14skippingpositivenonsmallcelllungcancer
AT yoshihiromiyata characteristiccomputedtomographyfeaturesinmesenchymalepithelialtransitionexon14skippingpositivenonsmallcelllungcancer
AT hironobuhamada characteristiccomputedtomographyfeaturesinmesenchymalepithelialtransitionexon14skippingpositivenonsmallcelllungcancer
AT kazuoawai characteristiccomputedtomographyfeaturesinmesenchymalepithelialtransitionexon14skippingpositivenonsmallcelllungcancer
AT noboruhattori characteristiccomputedtomographyfeaturesinmesenchymalepithelialtransitionexon14skippingpositivenonsmallcelllungcancer